Basit öğe kaydını göster

dc.contributor.authorBİLİCİ, A
dc.contributor.authorFAYDA, Emre Merdan
dc.contributor.authorUZUNOĞLU, S
dc.contributor.authorKARAGÖL, H
dc.contributor.authorUYGUN, K
dc.contributor.authorÇALOĞLU, M
dc.contributor.authorÇİÇİN, İ
dc.contributor.authorAKSU, G
dc.date.accessioned2021-03-03T10:54:15Z
dc.date.available2021-03-03T10:54:15Z
dc.date.issued2009
dc.identifier.citationUYGUN K., BİLİCİ A., KARAGÖL H., ÇALOĞLU M., ÇİÇİN İ., AKSU G., FAYDA E. M. , UZUNOĞLU S., "The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.64, sa.3, ss.601-605, 2009
dc.identifier.issn0344-5704
dc.identifier.othervv_1032021
dc.identifier.otherav_2538240b-a326-443e-86f9-4f2f76f7d7ce
dc.identifier.urihttp://hdl.handle.net/20.500.12627/29911
dc.identifier.urihttps://doi.org/10.1007/s00280-008-0911-7
dc.description.abstractSeveral studies have shown that the concurrent administration of chemotherapy (CHT) and radiotherapy (RT) is superior to RT alone in patients with inoperable non-metastatic squamous cell carcinoma of the head and neck (InSCCHN). We compared the efficacy and safety profile of RT and concurrent cisplatin CHT given in two different schedules to patients with previously untreated InSCCHN.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleThe comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck
dc.typeMakale
dc.relation.journalCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.contributor.departmentTrakya Üniversitesi , ,
dc.identifier.volume64
dc.identifier.issue3
dc.identifier.startpage601
dc.identifier.endpage605
dc.contributor.firstauthorID704951


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster